Interactions between NPY and CRF in the amygdala to regulate emotionality

Amaral, 2002, The primate amygdala and the neurobiology of social behavior: implication for understanding social phobia, Biol. Psychiatry, 51, 11, 10.1016/S0006-3223(01)01307-5

Bakshi, 2002, Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in the lateral septum or CRH1 receptors in the amygdala, J. Neurosci., 22, 2926, 10.1523/JNEUROSCI.22-07-02926.2002

Behan, 1996, Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders [comment], Mol. Psychiatry, 1, 265

Berglund, 2003, Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes, Exp. Biol. Med. (Maywood), 228, 217, 10.1177/153537020322800301

Brambilla, 2002, Anatomical MRI findings in mood and anxiety disorders, Epidemiologia e Psichiatria Sociale, 11, 88, 10.1017/S1121189X00005558

Britton, 1985, Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test, Psychopharmacology, 86, 170, 10.1007/BF00431704

Cannon, 1927, The James–Lange theory of emotion: a critical examination and an alternative theory, Am. J. Physiol., 39, 10

Carrasco, 2003, Neuroendocrine pharmacology of stress, Eur. J. Pharmacol., 235, 10.1016/S0014-2999(03)01285-8

Chalmers, 1995, Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rats brain: comparison with CRF1 receptor mRNA expression, J. Neurosci., 15, 6340, 10.1523/JNEUROSCI.15-10-06340.1995

Charney, 2004, Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress, Am. J. Psychiatry, 161, 195, 10.1176/appi.ajp.161.2.195

Chronwall, 1985, The anatomy of neuropeptide-Y-containing neurons in rat brain, Neuroscience, 15, 1159, 10.1016/0306-4522(85)90260-X

Cratty, 1995, Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces, Brain Res., 675, 297, 10.1016/0006-8993(95)00087-7

Dautzenberg, 2002, The CRF peptide family and their receptors: yet more partners discovered, Trends Pharmacol. Sci., 23, 71, 10.1016/S0165-6147(02)01946-6

Davidson, 2002, Anxiety and affective style: role of prefrontal cortex and amygdala, Biol. Psychiatry, 51, 68, 10.1016/S0006-3223(01)01328-2

Davidson, 2000, Dysfunction in the Neural circuitry of emotion regulation – a possible prelude to violence, Science, 289, 591, 10.1126/science.289.5479.591

Davis, 1992, The role of the amygdala in the fear-potentiated startle: implications for animlas models of anxiety, Trends Pharmacol. Sci., 13, 35, 10.1016/0165-6147(92)90014-W

Davis, 1998, Are different parts of the extended amygdala involved in fear versus anxiety?, Biol. Psychiatry, 44, 1239, 10.1016/S0006-3223(98)00288-1

Davis, 1997, Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD, Ann. NY Acad. Sci., 821, 305, 10.1111/j.1749-6632.1997.tb48289.x

Davis, 1993, Fear-potentiated startle: a neural and pharmacological analysis, Behav. Brain Res., 58, 175, 10.1016/0166-4328(93)90102-V

DeSouza, 1985, Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study, J. Neurosci., 3189, 10.1523/JNEUROSCI.05-12-03189.1985

Dumont, 1998, Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains, J. Comparative Neurol., 402, 372, 10.1002/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2

Feindel, 1954, Localization of discharge in temporal lobe automatism, Neurol. Psych., 72, 603

File, 1980, The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs, J. Neurosci. Methods, 2, 219, 10.1016/0165-0270(80)90012-6

Gehlert, 2002

Gilligan, 2000, Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents, J. Medicinal Chem., 43, 1641, 10.1021/jm990590f

Goosens, 2002, Long-term potentiation as a substrate for memory: evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning, Hippocampus, 12, 592, 10.1002/hipo.10099

Goosens, 2000, A role for amygdaloid PKA and PKC in the acquisition of long-term conditional fear memories in rats, Behav. Brain Res., 114, 145, 10.1016/S0166-4328(00)00224-2

Graeff, 1993, Role of the amygdala and periaqueductal gray in anxiety and panic, Behav. Brain Res., 58, 123, 10.1016/0166-4328(93)90097-A

Gray, 1986, Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system, Life Sci., 38, 389, 10.1016/0024-3205(86)90061-5

Gray, 1996, The amygdala: corticotropin-releasing factor, steroids, and stress, Crit. Rev. Neurobiol., 10, 155, 10.1615/CritRevNeurobiol.v10.i2.10

Hastings, 2001, NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro, Brain Res., 890, 32, 10.1016/S0006-8993(00)02874-2

Heilig, 1990, Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses, Acta Psychiatrica Scandinavica, 82, 95, 10.1111/j.1600-0447.1990.tb01366.x

Heilig, 1989, Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models, Psychopharmacologia, 98, 524, 10.1007/BF00441953

Heilig, 1993, Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects, Neuropsychopharmacology, 8, 357, 10.1038/npp.1993.35

Heilig, 1994, Corticotropin-releasing factor and neuropeptide Y: role in emotional integration, Trends Neurosci., 17, 80, 10.1016/0166-2236(94)90079-5

Heinrichs, 1992, Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action, Brain Res., 581, 190, 10.1016/0006-8993(92)90708-H

Heinrichs, 1997, Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior, Regulatory Peptides, 71, 15, 10.1016/S0167-0115(97)01005-7

Hilton, 1963, Amygdaloid region for defense reaction and its efferent pathway to the brainstem, J. Physiol., 165, 160, 10.1113/jphysiol.1963.sp007049

Hokfelt, 1991, Neuropeptides in perspective: the last ten years, Neuron, 7, 867, 10.1016/0896-6273(91)90333-U

Jensen, 1998, Comparison of sodium lactate-induced panic symptoms between panic disorder and posttraumatic stress disorder, Depress Anxiety, 7, 122, 10.1002/(SICI)1520-6394(1998)7:3<122::AID-DA4>3.0.CO;2-D

Kagamiishi, 2003, Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor, Brain Res., 991, 212, 10.1016/j.brainres.2003.08.021

Kapp, 1982, Cardiovascular responses elicited by electrical stimulation of the amygdala central nucleus in the rabbit, Brain Res., 416, 243

Kask, 1998, NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test, NeuroReport, 9, 2713, 10.1097/00001756-199808240-00005

Kask, 2001, Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety, Neuroscience, 104, 799, 10.1016/S0306-4522(01)00116-6

Kask, 2002, The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y, Neurosci. Biobehav. Rev., 26, 259, 10.1016/S0149-7634(01)00066-5

Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Arch. General Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002

Klüver, 1937, `Psychic blindness' and other symptoms following bilateral temporal lobectomy in rhesus monkeys, Am. J. Physiol., 119, 352

Koob, 1999, A role for corticotropin releasing factor and urocortin in behavioral responses to stressors, Brain Res., 848, 141, 10.1016/S0006-8993(99)01991-5

Krysiak, 1999, Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain, Neuropeptides, 33, 542, 10.1054/npep.1999.0776

Larhammar, 2001, Origins of the many NPY-family receptors in mammals, Peptides, 22, 295, 10.1016/S0196-9781(01)00331-X

Levita, 2003, Subtypes of substance P receptor immunoreactive interneurons in the rat basolateral amygdala, Brain Res., 981, 41, 10.1016/S0006-8993(03)02870-1

Lipp, 1988, Infrapyramidal mossy fibers and two-way avoidance learning: developmental modification of hippocampal circuitry and adult behavior of rats and mice, J. Neurosci., 8, 1905, 10.1523/JNEUROSCI.08-06-01905.1988

Maren, 1999, Long-term potentiation in the amygdala: a mechanism for emotional learning and memory [comment], Trends Neurosci., 22, 561, 10.1016/S0166-2236(99)01465-4

McDonald, 1989, Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala, Neurosci. Lett., 100, 53, 10.1016/0304-3940(89)90659-9

McEwen, 1993, Stress and the individual. Mechanisms leading to disease, Arch. Intern. Med., 153, 2093, 10.1001/archinte.153.18.2093

McKernan, 1997, Fear conditioning induces a lasting potentiation of synaptic currents in vitro, Nature, 390, 607, 10.1038/37605

Merali, 1998, Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala, J. Neurosci., 18, 4758, 10.1523/JNEUROSCI.18-12-04758.1998

Merlo Pich, 1995, Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis, J. Neurosci., 15, 5439, 10.1523/JNEUROSCI.15-08-05439.1995

Millan, 2003, The neurobiology and control of anxious states, Prog. Neurobiol., 70, 83, 10.1016/S0301-0082(03)00087-X

Narabayashi, 1963, Stereotaxic amygdalotomy for behavior disorders, Arch. Neurol., 9, 1, 10.1001/archneur.1963.00460070011001

Okuyama, 1999, Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001, J. Pharmacol. Exp. Therapeutics, 289, 926

Papez, 1937, A proposed mechanism of emotion, Arch. Neurol. Psychiatr., 38, 725, 10.1001/archneurpsyc.1937.02260220069003

Pasquini, 1994, Thyroid hormones and the central nervous system, Dev. Neurosci., 16, 1, 10.1159/000112080

Phillips, 1992, Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning, Behav. Neurosci., 106, 274, 10.1037/0735-7044.106.2.274

Pitts, 1967, lactate metabolism in anxiety neruosis, New England J. Med., 227, 1329, 10.1056/NEJM196712212772502

Rainey, 1987, A laboratory procedure for the induction of flashbacks, Am. J. Psychiatry, 144, 1317, 10.1176/ajp.144.10.1317

Rainnie, 2004, Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders, J. Neurosci., 24, 3471, 10.1523/JNEUROSCI.5740-03.2004

Rami, 1990, Delayed synaptogenesis in the dentate gyrus of the thyroid-deficient developing rat, Dev. Neurosci., 12, 398, 10.1159/000111867

Redrobe, 2004, Neuropeptide Y and its receptor subtypes in the central nervous system: Emphasis on their role in animals models of psychiatric disorders, 162, 101

Reul, 2002, Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression, Curr. Opin. Pharmacol., 2, 23, 10.1016/S1471-4892(01)00117-5

Roozendaal, 2001, Basolateral amygdala-nucleus accumbens interactions in mediating glucocorticoid enhancement of memory consolidation, J. Neurosci., 21, 2518, 10.1523/JNEUROSCI.21-07-02518.2001

Roozendaal, 2002, Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation, Proc. Natl. Acad. Sci. USA, 99, 13908, 10.1073/pnas.212504599

Sajdyk, 1997, Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acidA receptor blockade in the basolateral amygdala of rats, J. Pharmacol. Exp. Therapeutics, 283, 969

Sajdyk, 2000, Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala, Brain Res., 877, 226, 10.1016/S0006-8993(00)02638-X

Sajdyk, 1999, Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test, Eur. J. Pharmacol., 368, 143, 10.1016/S0014-2999(99)00018-7

Sajdyk, 1999, Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test, Eur. J. Pharmacol., 368, 143, 10.1016/S0014-2999(99)00018-7

Sajdyk, 1999, Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses, Behav. Brain Res., 100, 207, 10.1016/S0166-4328(98)00132-6

Sajdyk, 2002, Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats, Neuropharmacology, 43, 1165, 10.1016/S0028-3908(02)00234-4

Sanders, 1995, Regulation of anxiety by GABAA receptors in the rat amygdala, Pharm Biochem. Behav., 52, 1

Schwegler, 1991, Early postnatal hyperthyroidism alters hippocampal circuitry and improves radial-maze learning in adult mice, J. Neurosci., 11, 2102, 10.1523/JNEUROSCI.11-07-02102.1991

Shekhar, 2003, The amygdala, panic disorder, and cardiovascular responses, Ann. NY Acad. Sci., 985, 308, 10.1111/j.1749-6632.2003.tb07090.x

Sheriff, 2001, Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells, Peptides, 22, 2083, 10.1016/S0196-9781(01)00549-6

Skelton, 2000, Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems, J. Neurosci., 20, 1240, 10.1523/JNEUROSCI.20-03-01240.2000

Swanson, 1998, What is the amygdala?, Trends Neurosci., 21, 323, 10.1016/S0166-2236(98)01265-X

Tatemoto, 1982, Neuropeptide Y – a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide, Nature, 296, 659, 10.1038/296659a0

Thiele, 2004, Behavioral effects of neuropeptide Y, vol. 162

Thorsell, 1998, Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress, Regulatory Peptides, 75–76, 247, 10.1016/S0167-0115(98)00075-5

Thorsell, 1999, Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress, NeuroReport, 10, 3003, 10.1097/00001756-199909290-00024

Thorsell, 2000, Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression, Proc. Natl. Acad. Sci. USA, 97, 12852, 10.1073/pnas.220232997

Vale, 1981, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science, 213, 1394, 10.1126/science.6267699

Walker, 2003, Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety, Eur. J. Pharmacol., 199, 10.1016/S0014-2999(03)01282-2

Weiskrantz, 1956, Behavioral changes associated with ablation of the amygdaloid complex in monkeys, J. Comp. Physiol. Psychol., 4, 381, 10.1037/h0088009

Weiskrantz, 1956, Behavioral changes associated with ablation of the amygdaloid complex in monkeys, J. Comp. Physiol. Psychol., 49, 381, 10.1037/h0088009

Yilmazer-Hanke, 2004, Neuroscience, 124, 283, 10.1016/j.neuroscience.2003.12.004